JP2024532453A5 - - Google Patents
Info
- Publication number
- JP2024532453A5 JP2024532453A5 JP2024513543A JP2024513543A JP2024532453A5 JP 2024532453 A5 JP2024532453 A5 JP 2024532453A5 JP 2024513543 A JP2024513543 A JP 2024513543A JP 2024513543 A JP2024513543 A JP 2024513543A JP 2024532453 A5 JP2024532453 A5 JP 2024532453A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv infection
- gene
- gene coding
- hiv
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021115422 | 2021-08-30 | ||
| CNPCT/CN2021/115422 | 2021-08-30 | ||
| PCT/CN2022/115831 WO2023030315A1 (zh) | 2021-08-30 | 2022-08-30 | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532453A JP2024532453A (ja) | 2024-09-05 |
| JP2024532453A5 true JP2024532453A5 (https=) | 2025-09-17 |
Family
ID=85410861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513543A Pending JP2024532453A (ja) | 2021-08-30 | 2022-08-30 | エイズウイルス感染の遺伝子治療用の遺伝子配列構築体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240352096A1 (https=) |
| EP (1) | EP4397764A4 (https=) |
| JP (1) | JP2024532453A (https=) |
| CN (1) | CN118382699A (https=) |
| AU (1) | AU2022337765A1 (https=) |
| CA (1) | CA3230810A1 (https=) |
| WO (1) | WO2023030315A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12611466B2 (en) * | 2022-08-29 | 2026-04-28 | Shanghai Ophthal-Bright Biomedicine Technology | Modified vector, construction method, and application of modified AAV-8 serotype for gene targeting and expression |
| WO2025081292A1 (zh) * | 2023-10-16 | 2025-04-24 | 北京脑科学与类脑研究所 | 纳米抗体辅助的蛋白或多肽表达系统及制备和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101500615A (zh) * | 2006-08-17 | 2009-08-05 | 霍夫曼-拉罗奇有限公司 | 针对ccr5的抗体和抗融合肽的缀合物 |
| US8828932B2 (en) * | 2010-05-03 | 2014-09-09 | New York Blood Center, Inc. | Bifunctional molecules for inactivating HIV and blocking HIV entry |
| US8637024B2 (en) * | 2010-11-12 | 2014-01-28 | The Rockefeller University | Fusion antibodies for HIV therapy |
| CN104004092B (zh) * | 2014-06-05 | 2015-07-29 | 深圳市第三人民医院 | 单基因编码的双或多价特异性抗hiv免疫粘附素 |
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| EP3621649A2 (en) * | 2017-05-10 | 2020-03-18 | Albajuna Therapeutics, S.L. | Fc-fusion protein derivatives with high dual hiv antiviral and immunomodulatory activity |
| US12365722B2 (en) * | 2018-10-19 | 2025-07-22 | University Of Maryland, College Park | Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope |
| CN114645066B (zh) * | 2020-12-21 | 2023-08-25 | 康霖生物科技（杭州）有限公司 | 一种用于艾滋病基因治疗的核酸构建体 |
-
2022
- 2022-08-30 JP JP2024513543A patent/JP2024532453A/ja active Pending
- 2022-08-30 AU AU2022337765A patent/AU2022337765A1/en active Pending
- 2022-08-30 WO PCT/CN2022/115831 patent/WO2023030315A1/zh not_active Ceased
- 2022-08-30 US US18/687,689 patent/US20240352096A1/en active Pending
- 2022-08-30 CA CA3230810A patent/CA3230810A1/en active Pending
- 2022-08-30 EP EP22863450.7A patent/EP4397764A4/en active Pending
- 2022-08-30 CN CN202280056353.6A patent/CN118382699A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7724814B2 (ja) | Ｈｉｖ感染症の予防または処置のための三重特異性および／または三価結合タンパク質 | |
| CN107847591B (zh) | 多价人免疫缺陷病毒抗原结合分子及其应用 | |
| EP2571898B1 (en) | High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins | |
| JP2022101682A (ja) | ＨＩＶ ｇｐ１２０を標的化する抗体および使用方法 | |
| JP2020096630A5 (https=) | ||
| JP2020120689A5 (https=) | ||
| JP2025508118A (ja) | 新規免疫調節剤の開発および使用 | |
| CN118184774A (zh) | 中和SARS-CoV-2及变异株的全人源抗体及应用 | |
| JP2024532453A5 (https=) | ||
| WO2024125180A1 (zh) | 抗cd155的抗体及其应用 | |
| CN111944054A (zh) | 抗bcma的car及其表达载体和应用 | |
| CN121816190A (zh) | 双靶标car-t细胞在治疗b细胞自身免疫性疾病中的用途 | |
| EP4397764A1 (en) | Gene sequence construct for gene therapy of human immunodeficiency virus infection | |
| JP2024532426A5 (https=) | ||
| CN112661852A (zh) | 针对乙肝病毒的双特异性抗体及其应用 | |
| CN111944053A (zh) | 抗bcma的car及其表达载体和应用 | |
| EP4397748A1 (en) | Gene sequence construct for gene therapy for hiv infection | |
| EP4588937A1 (en) | Use of nkg2d-based cell adapter molecule in removal of aging cells | |
| JP2018534915A5 (https=) | ||
| US20240050567A1 (en) | Modified immune effector cell and use thereof | |
| CA2481325C (en) | Anti-hiv composition, production method thereof and medicament | |
| WO2023279803A1 (zh) | Rbv的蛋白结合分子及其用途 | |
| CN106892979A (zh) | 一种全人源抗h7n9病毒的中和抗体 | |
| WO2022122788A1 (en) | Multispecific antibodies against severe acute respiratory syndrome coronavirus 2 | |
| JPWO2010087131A1 (ja) | Ｈｉｖ複製抑制剤、及びその利用 |